Skip to main content
. 2021 Jul 16;65(8):e00095-21. doi: 10.1128/AAC.00095-21

FIG 3.

FIG 3

Ex vivo susceptibility to chloroquine in schizont maturation assays (SMA). Data are CQ IC50 in day 0 samples, stratified by treatment outcome. Dots indicate the type of recurrence based on identity-by-descent (IBD) analysis (black, IBD-homologous recurrence; gray, IBD-heterologous recurrence; white, undetermined by WGS). ACPR, adequate clinical and parasitological response.